4//SEC Filing
Hullinger Brian 4
Accession 0001062993-23-016939
CIK 0000806517other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 5:48 PM ET
Size
7.5 KB
Accession
0001062993-23-016939
Insider Transaction Report
Form 4
Hullinger Brian
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-08-17+100,000→ 100,000 totalExercise: $4.64Exp: 2033-08-17→ Common Stock, $.005 Par Value (100,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-17+200,000→ 200,000 totalExercise: $4.64Exp: 2033-08-17→ Common Stock, $.005 Par Value (200,000 underlying)
Footnotes (2)
- [F1]The option becomes exercisable with respect to 50% of the shares on August 17, 2024 and with respect to the remaining 50% on August 17, 2025.
- [F2]The option becomes exercisable, if at all, in two 100,000 share increments if the weighted average daily price of Psychemedics Corporation's common stock on the Nasdaq Stock Market during any 60 consecutive calendar day period exceeds $5.50 and $6.50, respectively.
Issuer
PSYCHEMEDICS CORP
CIK 0000806517
Entity typeother
Related Parties
1- filerCIK 0001987597
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 5:48 PM ET
- Size
- 7.5 KB